L

LEVY J.

Last name: LEVY J.

2018 (v1)

Publication

Metadata-only

Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: Results from the 5-year long-term extension of the phase III pivotal trials

Ruperto N. Brunner H. I. Quartier P.

Objectives To evaluate the long-term efficacy and safety of canakinumab in patients with active systemic juvenile idiopathic arthritis (JIA). Methods Patients (2-19 years) entered two phase III studies and continued in the long-term extension (LTE) study. Efficacy assessments were performed every 3 months, including adapted JIA American College...

Uploaded on: October 11, 2023